AL
CNCE

Airain Ltd’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Airain Ltd’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$215K Buy
+15,424
New +$227K 0.01% 741
2015
Q4 		– Sell
-22,126
Closed -$415K – 1100
2015
Q3 		$415K Buy
+22,126
New +$376K 0.02% 510

Other funds holding CNCE

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
LSC
Lyon Street Capital Sausalito, California $67M AUM

Airain Ltd's CNCE Position: Q2 2017 in Review

Airain Ltd opened a new position in Concert Pharmaceuticals, Inc. (CNCE) in Q2 2017: 15,424 shares worth $215K. The stake represents 0.01% of the portfolio and ranks #741 among its holdings. This is a return to the name: Airain Ltd previously reported a position in CNCE as recently as Q3 2015.

Airain Ltd first reported a position in CNCE in Q3 2015 and has held it in 2 quarters since. The position peaked at $415K in Q3 2015. 79 funds tracked by Wall St. Rank hold CNCE as of Q2 2017.

  • Airain Ltd held 15,424 shares of Concert Pharmaceuticals, Inc. worth $215K as of Q2 2017.
  • Concert Pharmaceuticals, Inc. was a new Airain Ltd position in Q2 2017.
  • Concert Pharmaceuticals, Inc. made up 0.01% of Airain Ltd's portfolio in Q2 2017, its #741 holding.
  • Airain Ltd first reported a position in Concert Pharmaceuticals, Inc. in Q3 2015 and has held it in 2 quarters since.
  • Airain Ltd's Concert Pharmaceuticals, Inc. position peaked at $415K in Q3 2015.
  • 79 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.